| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $723.9M | +10.9% |
| Cost of Revenue | $77.2M | +19.6% |
| Gross Profit | $646.7M | +10.0% |
| R&D Expense | $341.5M | +5.2% |
| SG&A Expense | $152.0M | +7.5% |
| Operating Income | -$266.7M | +1.2% |
| Pre-tax Income | -$250.8M | +1.0% |
| Income Tax | $4.8M | +28.6% |
| Net Income | -$255.5M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $184.7M | -21.9% |
| Accounts Receivable | $87.6M | -0.9% |
| Current Assets | $600.7M | -8.9% |
| Total Assets | $891.4M | -7.3% |
| Current Liabilities | $415.8M | +13.2% |
| Total Liabilities | $663.9M | +4.5% |
| Stockholders' Equity | $227.5M | -30.3% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.9M | +183.2% |
| Capital Expenditures | $5.6M | -27.9% |
| Investing Cash Flow | -$6.1M | +97.9% |
| Financing Cash Flow | -$58.1M | -446.3% |
| Free Cash Flow | $9.4M | +136.5% |
| +0.6% |
| EPS (Basic) | -$1.11 | +5.1% |
| EPS (Diluted) | -$1.11 | +5.1% |